Serological screening for Leishmania infantum in asymptomatic blood donors and HIV+ patients living in an endemic area;Screening sierologico per Leishmania infantum su donatori di sangue e HIV+ asintomatici residenti in area endemica

Infezioni in Medicina

Volumn 16, Issue 1, 2008, Pages 21-27

  Scarlata, Francesco ^a   Li Vecchi, Valentina ^a   Abbadessa, Vincenzo ^b   Giordano, Salvatore ^a   Infurnari, Laura ^a   Saporito, Laura ^a   Mancuso, Salvatrice ^b   Occhipinti, Francesco ^c   Vitale, Fabrizio ^d   Reale, Stefano ^d   Titone, Lucina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Servizio Riferimento Regionale AIDS e Sindromi Correlate   (Italy)

^c Ospedale S Giovanni di Dio   (Italy)

^d ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA SICILIA A MIRRI   (Italy)

Author keywords

Blood donors; Coinfection; HIV; Leishmaniasis

Indexed keywords

DNA; PROTOZOON ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; ITALY; LEISHMANIA INFANTUM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SCREENING TEST; SERODIAGNOSIS; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, PROTOZOAN; BLOOD DONORS; ENDEMIC DISEASES; FEMALE; HIV SEROPOSITIVITY; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; SEROLOGIC TESTS;

EID: 42049088702     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sinha P.K., Pandey K., Bhattacharya S.K. Diagnosis e management of leishmania/HIV co-infection. Indian J. Med. Res. 121, 407-414, 2005.
2. Cascio A., Colomba C. La leishmaniosi viscerale in età pediatrica. Infez. Med. 1, 5-10, 2003.
3. Leishmania/HIV co-infection. Epidemiological analisis of 692 retrospective cases. Wkly Epidemiol. Rec. 72, 49-54, 1997.
4. Reale S., Maxia L., Vitale F., et al. Detection of leishmania infantum in dogs by PCR with lymph node aspirates and blood. J. Clin. Microbiol. 37, 2931-2935, 1999.
5. Badarò R., Jones T.C., Lorenco R., et al. A prospective study of visceral leshmaniasis in an endemic area of Brazil. J. Infect. Dis. 154, 639-649, 1986.
6. Jeronimo S.M., Teixeira M.J., Sousa A., Thielkinq P., Pearson R.D, Evans T.G. Natural history of Leishmania chagasi infection in Northeastern Brazil: long term follow-up. Clin. Infect. Dis. 30, 608-609, 2000.
7. Le Fichoux Y., Quaranta J.F., Aufeuvre J.P., et al. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in area of endemicity in Southern France. J. Clin. Microbiol. 37, 1953-1957, 1999.
8. Luz K.G., da Silva D.O., Gomes E.M., et al. Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and polytrasfused hemodialyzed patients. Am. J. Trop. Med. Hyg. 57, 168-171, 1997.
9. Mosier D., Sieburg H. Macrophage-tropic HIV: critical for AIDS pathogenesis. Immunol. Today. 15, 332-339, 1994.
10. Olivier M., Badaro S., Medrano F.J., Moreno J. The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanism. Ann. Trop. Med. Parassitol. 97, 79-98, 2003.
11. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Ann. Rev. Immunol. 13, 151-177, 1995.
12. Alvar J., Canavate C., Gutierrez-Solair B., et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10, 298-319, 1997.
13. Kubar J., Marty P., Lelièvre A., et al. Visceral Leishmaniasis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphcyte counts. AIDS 12, 2147-2153, 1998.
14. Casado J.L., Lopez-Velez R., Pintado V., Quereda C., Antela A., Moreno S. Relapsing visceral leishmaniasis in HIV infected patients undergoing successful protease inhibitor therapy. Eur. J. Clin. Microbiol. Infect. Dis. 20, 201-205, 2001.
15. Kaplan J.E., Hanson M.S., Dworkin T., et al. Epidemiology of human immunodefiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 30, 5-14, 2000.
16. de La Rosa R., Pineda J.A., Delgado J., et al. Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy. J. Clin. Microbiol. 40, 3, 762-767, 2002.
17. Cruz I., Morales M.A., Noquer I., Rodriquez A., Alvar J. Leishmania in discarded syringes from intravenous drug users. Lancet. 359, 1124-1125, 2002.
18. Desieux P., Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann. Trop. Med. Parassitol. 97, 3-15, 2003.
19. Garrote J.I., Gutierrez M.P., Izquierdo R.L., et al. Seroepidemiologic study of Leishmania infantum infection in Castilla-Leon, Spain. Am. J. Trop. Med. Hyg. 71, 403-406, 2004.
20. Otero A.C.S., da Silva V.O., Luz K.G., et al. Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive brazilian blood donors. Am. J. Trop. Med. Hyg. 62, 128-131, 2000.
21. Riera C., Fisa R., Udina M., Gallego M., Portus M. Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Island, Spain) by different diagnostic metods. R. Soc. Trop. Med. Hyg. 98, 102-110, 2004.
22. Colomba C., Saporito L., Frasca Polara V., Barone T., Corrao A, Titone L. Serological screening for Leishmania infatum asymptomatic blood donors living in an endemic area (Sicily, Italy). Trasf. Aph. Science. 33, 311-314, 2005.
23. Kubar J., Marty P., Lelièvre A., et al. Visceral leishmaniosis in HIV- positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS 12, 2147-2153, 1998.
24. Scarlata F., Rubino R., Giordano S. Diagnostica delle zoonosi. Giornale Italiano di Malattie Infettive. 12, 132-136, 2006.